[Platelet activation in relapse idiopathic nephrotic syndrome in children]

M Tkaczyk1, Z Baj, M Nowicki

  • 1Klinika Nefrologii i Dializoterapii, Instytutu Centrum Zdrowia Matki Polki. mtkaczyk@krysia.uni.lodz.pl

Insights

Platelet activation is increased in children with idiopathic nephrotic syndrome (INS) relapses, posing a risk for blood clots. This activation, marked by aggregates and microparticles, decreases with early treatment.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Thrombosis Research

Background:

  • The role of platelets in pediatric idiopathic nephrotic syndrome (INS) pathogenesis and thromboembolic complications is not fully understood.
  • Platelet activation is a potential factor in the development of complications associated with INS relapses.

Purpose of the Study:

  • To analyze platelet activation in whole blood during the initial 8 weeks of idiopathic nephrotic syndrome (INS) in children.
  • To investigate markers of platelet activation and their correlation with clinical parameters during INS relapses.

Main Methods:

  • Assessed platelet aggregates, microparticles, and surface markers (CD62P, CD42b) in 24 children with INS relapses and 16 healthy children.
  • Evaluated activation markers at the onset of INS and after 2 weeks of therapy.
  • Compared results between the INS patient group and the healthy control group.

Main Results:

  • Increased counts of platelet aggregates and microparticles were observed at the onset of INS.
  • A systematic decrease in these markers was noted within the first 2 weeks of therapy.
  • Significantly lower expression of CD42b was found at the beginning of treatment, with no clear correlation to biochemical parameters.

Conclusions:

  • Increased blood platelet activation is an independent risk factor for thromboembolic complications in the early stages of INS relapse.
  • The precise role of platelets in the pathogenesis or induction of INS relapses requires further investigation.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...